• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Congressman calls for U.S. to join international trial, disease initiatives

Congressman calls for U.S. to join international trial, disease initiatives

November 15, 2013
CenterWatch Staff

In a speech to the European Commission, U.S. Representative Chaka Fattah of Pennsylvania reiterated American support for international brain research collaboration and pledged his commitment to engaging the U.S. in two E.U.-led initiatives around clinical trials and neurodegenerative diseases.

Speaking live via video to the Commission's Joint Research Center (JRC) conference on public health in Brussels, Fattah said he will push for the U.S. to join the E.U.'s Joint Programming Initiative on Neurodegenerative Disease Research (JPND), as well as the European and Developing Countries Clinical Trials Partnership (EDCTP).

Fattah said he will work with the administration and the White House Office of Science and Technology Policy (OSTP) to involve the U.S. in each of these efforts.

Both initiatives are globally focused and center on sharing techniques and research among participating member countries. JPND is the largest and most advanced global research initiative designed to tackle neurodegenerative diseases including Alzheimer's. In 2012, Israel and Canada were accepted, joining 25 other member countries as partners. The EDCTP was launched in 2003 as a European response to the global health crisis caused by HIV/AIDS, tuberculosis and malaria. Together with its 16 partner countries, EDCTP aims to accelerate the development of new or improved drugs and vaccines against these three main poverty-related diseases.

Fattah lauded the extraordinary work of the E.U. in its efforts around public health and science research, calling it a "model" for nations around the world to pursue, and he affirmed the importance of international cooperation.

"We need to have better cooperation and coordination on these efforts," Fattah said. "Relationships have to be built around actual cooperative work. I am looking at this issue, not just as an American official, but as a global citizen."

The speech to JRC, the European Commission's in-house scientific research service, was Fattah's third neuroscience speech to an international community in the past six months through his advocacy work as architect of the Fattah Neuroscience Initiative. The initiative, established in 2011, is a non-incremental policy effort seeking to achieve progress in understanding the human brain.

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing